oxprenolol has been researched along with Shock, Cardiogenic in 2 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smulski, H | 1 |
| Sawiński, J | 1 |
| Fiedorowicz-Fabrycy, I | 1 |
| Delacour, JL | 1 |
| Blanc, PL | 1 |
| Wagschal, G | 1 |
| Daoudal, P | 1 |
2 other studies available for oxprenolol and Shock, Cardiogenic
| Article | Year |
|---|---|
[Irreversible cardiogenic shock in a patient with implanted pacemaker following on oral dose of oxprenolol (Coretal-Polfa)].
Topics: Administration, Oral; Autopsy; Heart Block; Humans; Male; Middle Aged; Oxprenolol; Pacemaker, Artifi | 1975 |
[Hemodynamic aspect of adiastole in oxprenolol poisoning].
Topics: Diastole; Dopamine; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Oxprenolol; Shock, Cardi | 1986 |